Abstract : Myoepithelial carcinoma is a rare salivary gland tumour which accounts for less than 1% of all salivary gland tumours. Donath et al in 1972 introduced the term epithelial-myoepithelial carcinoma by noting the myoepithelial component as an integral part of the tumor. In 1991, the WHO recognized EMC as a distinct entity and subtype of salivary gland adenocarcinoma which became a part of the new classification system 1. Clinical and radiological findings often mimic a benign parotid tumor. Because of rarity of EMC, a standard treatment guideline is not yet known. Surgical resection is the most widely used approach. Local recurrence rates of 23–50 % have been reported with 25 % chance of distant metastasis. Patients with histo-pathologic markers of aggressive disease should be considered for adjuvant radiotherapy. Here we describe a case which presented in 59-year-old female as a swelling below left ear. Complete resection of the gland was done and post-operative radiotherapy was advised.